All in Favor

At his blog, PhysioProf discusses the difference between basic and applied research, adding that "even if you think that the only reason for doing science is to treat people, you should still be in favor of basic research." After all, discoveries made in the basic arena -- he points to small noncoding RNAs as an example -- wind up being used to try to treat people.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.